Detalles de la búsqueda
1.
Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival.
Cancer Immunol Immunother
; 72(4): 945-954, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36197494
2.
Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis.
Acta Derm Venereol
; 103: adv12445, 2023 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37622204
3.
Correction to: Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival.
Cancer Immunol Immunother
; 72(4): 955, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36538061
4.
Comparative efficacy and safety of tisagenlecleucel and axicabtagene ciloleucel among adults with r/r follicular lymphoma.
Leuk Lymphoma
; 65(3): 323-332, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38179688
5.
Incidence of pneumococcal disease in children ≤48 months old in the United States: 1998-2019.
Vaccine
; 42(11): 2758-2769, 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485640
6.
Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting.
Gynecol Oncol Rep
; 51: 101332, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38362364
7.
Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.
JAMA Dermatol
; 159(4): 411-418, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36857069
8.
All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States.
J Manag Care Spec Pharm
; 28(4): 426-434, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35332790
9.
Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States.
Leuk Lymphoma
; 63(9): 2052-2062, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35422192
10.
The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United States.
Adv Ther
; 39(2): 943-958, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34918193
11.
Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata.
J Health Econ Outcomes Res
; 9(2): 11-18, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35975139
12.
Canine Lafora Disease: An Unstable Repeat Expansion Disorder.
Life (Basel)
; 11(7)2021 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34357061
13.
Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.
Cell Rep
; 27(5): 1334-1344.e6, 2019 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31042462
14.
Nationwide genetic testing towards eliminating Lafora disease from Miniature Wirehaired Dachshunds in the United Kingdom.
Canine Genet Epidemiol
; 5: 2, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29610669
15.
Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States.
J Med Econ
; 26(1): 441-444, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36896625
16.
Correction to: Nationwide genetic testing towards eliminating Lafora disease from Miniature Wirehaired Dachshunds in the United Kingdom.
Canine Med Genet
; 8(1): 14, 2021 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34961559
Resultados
1 -
16
de 16
1
Próxima >
>>